Compare WYFI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WYFI | BIOA |
|---|---|---|
| Founded | 2023 | 2015 |
| Country | United States | United States |
| Employees | 83 | 62 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 953.8M | 967.7M |
| IPO Year | N/A | N/A |
| Metric | WYFI | BIOA |
|---|---|---|
| Price | $26.58 | $10.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | $29.20 | ★ $51.50 |
| AVG Volume (30 Days) | ★ 2.7M | 1.1M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $80.46 | $720.93 |
| Revenue Next Year | $89.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.51 | $4.26 |
| 52 Week High | $46.87 | $25.96 |
| Indicator | WYFI | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 30.01 |
| Support Level | N/A | $7.61 |
| Resistance Level | N/A | $13.78 |
| Average True Range (ATR) | 0.00 | 1.51 |
| MACD | 0.00 | -1.52 |
| Stochastic Oscillator | 0.00 | 13.63 |
Whitefiber Inc is a provider of artificial intelligence infrastructure solutions. The company owns high-performance computing data centers and provide cloud-based HPC graphics processing units services, which it terms cloud services, for customers such as AI application and machine learning developers. Its Tier-3 data centers provide hosting and colocation services. Its cloud services support generative AI workstreams, especially training and inference. It has two reportable segments: cloud services and colocation services. The cloud services segment generates revenue from providing high performance computing services to support generative AI workstreams. Colocation services generate revenue by providing customers with physical space, power and cooling within the data center facility.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.